The MMR IHC Panel PharmaDx (Dako Omnis) is used to identify loss of function in mismatch repair proteins and inform the treatment of colorectal cancer patients.

A European consensus statement says antithrombotic treatment for acute coronary syndromes should adjust for sex differences ...

In this video, James E. Galvin, MD, MPH, discusses the SHIMMER study, presented at the Alzheimer’s Association International ...

NSCLC represents 80% of lung cancer cases and is the leading cause of cancer-related mortality globally. This designation is ...

Those who have recently purchased the recalled raw frozen shrimp from Walmart should throw them away immediately, the FDA ...

Proteomics has emerged as a groundbreaking tool. But where are we in the evolution of these methods, and how exactly are they ...

Bristol-Myers Squibb Company announced a significant update on their Phase 3 lung cancer trial. The study tests two promising ...

Pigot most recently served as chief commercial officer at Aerovate Therapeutics, which was developing a dry powder inhaled ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers Squibb is conducting the ...

Bristol-Myers Squibb Company (($BMY)) announced an update on their ongoing clinical study. Study Overview: Bristol-Myers ...

The American College of Cardiology has established a digital hypertrophic cardiomyopathy (HCM) registry to learn more about ...